Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13239 | 786 | 25.3 | 63% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
217 | 20084 | ANESTHESIOLOGY//PROPOFOL//DEXMEDETOMIDINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LANDIOLOL | Author keyword | 39 | 61% | 5% | 42 |
2 | ESMOLOL | Author keyword | 37 | 39% | 9% | 74 |
3 | ONO 1101 | Author keyword | 6 | 80% | 1% | 4 |
4 | ESTER FUNCTIONAL GROUP | Author keyword | 4 | 75% | 0% | 3 |
5 | HEART QT INTERVAL | Author keyword | 4 | 75% | 0% | 3 |
6 | SYMPATHETIC NERVOUS SYSTEM BETA ADRENERGIC ANTAGONISTS | Author keyword | 4 | 75% | 0% | 3 |
7 | INTUBATION TRACHEAL HEMODYNAMIC RESPONSE | Author keyword | 3 | 100% | 0% | 3 |
8 | COMPLICATIONS HYPERTENSION | Author keyword | 3 | 27% | 1% | 9 |
9 | BRADYCARDIC EFFECT | Author keyword | 2 | 67% | 0% | 2 |
10 | HEART ESMOLOL | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACTING BETA BLOCKER | 30 | 60% | 4% | 33 |
2 | ESMOLOL | 28 | 33% | 9% | 70 |
3 | ONO 1101 | 26 | 68% | 3% | 23 |
4 | Q T INTERVAL | 7 | 23% | 4% | 28 |
5 | LARYNGOSCOPY | 5 | 10% | 7% | 52 |
6 | HIGH DOSE ESMOLOL | 3 | 100% | 0% | 3 |
7 | CATECHOLAMINE RESPONSES | 3 | 13% | 3% | 20 |
8 | CORRECTION FORMULAS | 2 | 32% | 1% | 6 |
9 | ATTENUATES CARDIOVASCULAR RESPONSES | 2 | 67% | 0% | 2 |
10 | BETA BLOCKER ESMOLOL | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity | 2014 | 6 | 136 | 50% |
Esmolol A Review of its Use in the Short-Term Treatment of Tachyarrhythmias and the Short-Term Control of Tachycardia and Hypertension | 2012 | 8 | 49 | 67% |
The Safety of Perioperative Esmolol: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | 2011 | 9 | 63 | 63% |
Clinical Pharmacokinetics and Therapeutic Efficacy of Esmolol | 2012 | 6 | 53 | 57% |
The efficacy of landiolol for suppressing the hyperdynamic response following laryngoscopy and tracheal intubation: a systematic review | 2009 | 4 | 24 | 83% |
ESMOLOL - A REVIEW OF ITS THERAPEUTIC EFFICACY AND PHARMACOKINETIC CHARACTERISTICS | 1995 | 45 | 46 | 74% |
Prolonged QT Syndrome and Sedation A Case Report and a Review of the Literature | 2011 | 3 | 17 | 82% |
Efficacy of intravenous lidocaine versus placebo on attenuating cardiovascular response to laryngoscopy and tracheal intubation: a systematic review of randomized controlled trials | 2013 | 3 | 57 | 33% |
The influence of anesthesia on cardiac repolarization | 2012 | 4 | 104 | 51% |
Long QT syndrome and anaesthesia | 2003 | 65 | 103 | 28% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANAESTHESIA NEUROSURG | 1 | 50% | 0.1% | 1 |
2 | ANESTEZIYOLOJI AD | 1 | 50% | 0.1% | 1 |
3 | MCDERMOTT CHAIR ANESTHESIOL | 1 | 50% | 0.1% | 1 |
4 | ANESTESIOL REANIMACAO | 1 | 22% | 0.3% | 2 |
5 | GLOBAL HLTH ECON POLICY | 0 | 33% | 0.1% | 1 |
6 | NURSE ANESTHESIA EDUC | 0 | 33% | 0.1% | 1 |
7 | ANAESTHESIOL PAIN | 0 | 25% | 0.1% | 1 |
8 | ANASTHESIOL REANIMAT | 0 | 25% | 0.1% | 1 |
9 | AUSTRALIAN NEW ZEALAND INTENS CARE SOC | 0 | 25% | 0.1% | 1 |
10 | CARDIOVASC CARDIAC ARRHYTHMIA | 0 | 25% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189378 | EYE INTRAOCULAR PRESSURE//ANAESTHESIOL GEN INTENS CARE A//OPHTHALMOL OPTOMETR |
2 | 0.0000126919 | HEART CORONARY ARTERY DISEASE//ARTERIES CORONARY STEAL//PHARMACOLOGY NIFEDIPINE |
3 | 0.0000098436 | HEART ARRHYTHMIAS//ANESTHETICS VOLATILE HALOTHANE//SUBSIDIARY ATRIAL PACEMAKERS |
4 | 0.0000087880 | CLEVIDIPINE//HYPERTENSIVE EMERGENCY//HYPERTENSIVE CRISIS |
5 | 0.0000082103 | REMIFENTANIL//TARGET CONTROLLED INFUSION//EQUIPMENT DIPRIFUSOR TARGET CONTROLLED INFUSION |
6 | 0.0000079252 | CONTROLLED HYPOTENSION//SURGICAL FIELD//HYPOTENSION CONTROLLED |
7 | 0.0000076477 | NORFENTANYL//MUSCULAR RIGIDITY//SUFENTANIL |
8 | 0.0000063558 | LONG QT SYNDROME//KCNQ1//SHORT QT SYNDROME |
9 | 0.0000059243 | COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER |
10 | 0.0000058786 | QT DISPERSION//QT INTERVAL//THOROUGH QT STUDY |